| A prospective observational study of medication errors in a tertiary care emergency department AE Patanwala, TL Warholak, AB Sanders, BL Erstad Annals of emergency medicine 55 (6), 522-526, 2010 | 152 | 2010 |
| Ability of pharmacy clinical decision-support software to alert users about clinically important drug—drug interactions KR Saverno, LE Hines, TL Warholak, AJ Grizzle, L Babits, C Clark, ... Journal of the American Medical Informatics Association 18 (1), 32-37, 2011 | 150 | 2011 |
| Analysis of community chain pharmacists’ interventions on electronic prescriptions TL Warholak, MT Rupp Journal of the American Pharmacists Association 49 (1), 59-64, 2009 | 120 | 2009 |
| Evaluation of e-prescribing in chain community pharmacy: best-practice recommendations MT Rupp, TL Warholak Journal of the American Pharmacists Association 48 (3), 364-391a, 2008 | 96 | 2008 |
| Physicians' opinions of a health information exchange AL Hincapie, TL Warholak, AC Murcko, M Slack, DC Malone Journal of the American Medical Informatics Association 18 (1), 60-65, 2011 | 85 | 2011 |
| Analysis of pharmacists’ interventions on electronic versus traditional prescriptions in 2 community pharmacies AM Gilligan, K Miller, A Mohney, C Montenegro, J Schwarz, TL Warholak Research in social and administrative pharmacy 8 (6), 523-532, 2012 | 77 | 2012 |
| Integrating innovative telehealth solutions into an interprofessional team-delivered chronic care management pilot program AM Taylor, J Bingham, K Schussel, DR Axon, DJ Dickman, K Boesen, ... Journal of managed care & specialty pharmacy 24 (8), 813-818, 2018 | 69 | 2018 |
| Medication error identification rates by pharmacy, medical, and nursing students TL Warholak, C Queiruga, R Roush, H Phan American journal of pharmaceutical education 75 (2), 24, 2011 | 55 | 2011 |
| Health disparities in cost of care in patients with Alzheimer’s disease: An analysis across 4 state Medicaid populations AM Gilligan, DC Malone, TL Warholak, EP Armstrong American Journal of Alzheimer's Disease & Other Dementias® 28 (1), 84-92, 2013 | 51 | 2013 |
| An exploratory comparison of medication lists at hospital admission with administrative database records TL Warholak, M McCulloch, A Baumgart, M Smith, W Fink, W Fritz Journal of Managed Care Pharmacy 15 (9), 751-758, 2009 | 51 | 2009 |
| Effect of patient information on the quality of pharmacists’ drug use review decisions T Warholak-Juarez, MT Rupp, TA Salazar, S Foster Journal of the American Pharmaceutical Association (1996) 40 (4), 500-507, 2000 | 51 | 2000 |
| A systematic review of the prevalence and diagnostic workup of PIK3CA mutations in HR+/HER2–metastatic breast cancer EJ Anderson, LE Mollon, JL Dean, TL Warholak, A Aizer, EA Platt, ... International Journal of Breast Cancer 2020, 2020 | 50 | 2020 |
| Evaluation of an academic-community partnership to implement MTM services in rural communities to improve pharmaceutical care for patients with diabetes and/or hypertension M Johnson, R Jastrzab, J Tate, K Johnson, E Hall-Lipsy, R Martin, ... Journal of managed care & specialty pharmacy 24 (2), 132-141, 2018 | 50 | 2018 |
| Evaluation of risk factors and health outcomes among persons with asthma K Smith, T Warholak, E Armstrong, M Leib, R Rehfeld, D Malone Journal of Asthma 46 (3), 234-237, 2009 | 50 | 2009 |
| Electronic prescribing problems reported to the Pharmacy and Provider ePrescribing Experience Reporting (PEER) portal AL Hincapie, T Warholak, A Altyar, R Snead, T Modisett Research in Social and Administrative Pharmacy 10 (4), 647-655, 2014 | 43 | 2014 |
| A systematic literature review of the prevalence of PIK3CA mutations and mutation hotspots in HR+/HER2-metastatic breast cancer L Mollon, A Aguilar, E Anderson, J Dean, L Davis, T Warholak, AA Aizer, ... Cancer Research 78 (13_Supplement), 1207-1207, 2018 | 41 | 2018 |
| A cost-effectiveness evaluation of hospital discharge counseling by pharmacists C Chinthammit, EP Armstrong, TL Warholak Journal of pharmacy practice 25 (2), 201-208, 2012 | 41 | 2012 |
| A systematic literature review of the prognostic and predictive value of PIK3CA mutations in HR+/HER2− metastatic breast cancer LE Mollon, EJ Anderson, JL Dean, TL Warholak, A Aizer, EA Platt, ... Clinical Breast Cancer 20 (3), e232-e243, 2020 | 38 | 2020 |
| The impact of health information exchange on health outcomes A Hincapie, T Warholak Applied clinical informatics 2 (04), 499-507, 2011 | 38 | 2011 |
| Pharmacists’ awareness of clinical decision support in pharmacy information systems: an exploratory evaluation LE Hines, KR Saverno, TL Warholak, A Taylor, AJ Grizzle, JE Murphy, ... Research in Social and Administrative Pharmacy 7 (4), 359-368, 2011 | 36 | 2011 |
